Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis
Jeffrey H. Lin(University of Pennsylvania), Robert H. Vonderheide(University of Pennsylvania)
Cited by 175
Related Papers
Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
|Cancer Immunology Research|2015|467
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in <i>BRCA1</i>, <i>BRCA2</i>, or <i>PALB2</i>
|Journal of Clinical Oncology|2021|238
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer
|Clinical Cancer Research|2021|178
Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious <i>BRCA</i> Mutation
|JCO Precision Oncology|2018|177
The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder
|American Journal of Transplantation|2015|174